GO
Loading...

Mergers

More

  • Want a job? We'll buy your company: Tech giants Sunday, 9 Nov 2014 | 12:00 PM ET
    Yahoo! headquarters in Sunnyvale, Calif.

    Some investors are taking aim at "acqui-hiries"—the trend of a big company buying a start-up for the sake of raiding its talent.

  • BOSTON, Nov 7- Valeant Pharmaceuticals International Inc can pay "substantially" more for Allergan Inc and should get a fair shot at buying it, William Ackman, the Botox maker's biggest shareholder, said on Friday. Ackman wrote to Allergan's board the day after the company said it was discussing a merger with another company, widely reported to be Actavis, to fend...

  • BOSTON, Nov 7- Valeant Pharmaceuticals International Inc can pay "substantially" more for Allergan Inc and should get a fair shot at buying it, William Ackman, the Botox maker's biggest shareholder, said on Friday. Ackman said this in a letter to Allergan's board the day after the company said it was discussing a merger with another company, widely reported to be...

  • *Telecom Italia CEO says "mandatory" to explore deal with Oi. *Brazil remains strategic, but sale of local unit possible. MILAN, Nov 7- Telecom Italia must explore the possibility of buying or merging with Brazilian telecoms operator Oi, CEO Marco Patuano said on Friday, as the company tries to strengthen the position of its local subsidiary.

  • LONDON, Nov 7- British Airways owner IAG laid out plans to pay a maiden dividend, coming of age three years after it was created in a merger between BA and Spain's Iberia. International Airlines Group said it was confident of increasing profit by more than 10 percent a year between 2016 and 2020, on top of significant growth this year and next. BA and Iberia sealed an...

  • LONDON, Nov 6- AstraZeneca, which saw off a $118 billion bid from Pfizer in May, said quarterly results showed its standalone strength, while recent U.S. tax changes removed much of the case for a new takeover attempt. Chief Executive Pascal Soriot, who has fought hard to prove AstraZeneca does not need the kind of mega-merger offered by Pfizer, said he would use the...

  • BOSTON, Nov 5- Hedge fund Elliott Associates may take legal action against pharmaceuticals company AbbVie Inc for scuttling a merger deal with Shire Plc. Elliott said in a quarterly letter to investors that it was disappointed when AbbVie's board withdrew its support for the deal in October after executives had signaled strong interest in late September.

  • WASHINGTON, Nov 4- When Marcelo Claure took the top job at Sprint Corp two months ago, he faced an uphill climb in turning around the No. 3 U.S. cellular provider. The Bolivian entrepreneur, who was installed as CEO after the collapse of merger talks with T-Mobile US Inc, already faced the task of stemming growing subscriber defections as the company seeks to upgrade...

  • The wealth funds clinching the most deals are Tuesday, 4 Nov 2014 | 12:12 AM ET

    Singapore's Temasek and GIC were the most active sovereign wealth funds last year, closing deals even as their peers' efforts slackened, a report said.

  • WASHINGTON, Nov 3- The U.S. Justice Department on Monday filed a lawsuit to block National CineMedia Inc's proposed $375 million acquisition of smaller rival Screenvision LLC, a deal that would significantly concentrate a niche advertising market. National CineMedia's shares were down 22 percent on Monday, after being halted prior to the Justice...

  • *Publicis aims to boost growth after failed Omnicom merger. The French group is hoping rapid growth in both North American and Internet advertising, which are far outpacing European and traditional ad formats, will help it catch up with sales gains at rivals such as WPP and Interpublic. Chief Executive Maurice Levy has blamed Publicis' recent poor performance...

  • LISBON, Nov 3- Telecoms group Altice SA has made a bid worth 7.03 billion euros for the Portuguese operations of Brazil's Oi as Oi unwinds its troubled merger with Portugal Telecom. Oi's new interim chief executive, Bayard Gontijo, said last month that the company could sell Portuguese assets acquired with its takeover of Portugal Telecom in order to pay down...

  • *Disposals needed for regulatory approval of Lafarge merger. ZURICH, Nov 3- Switzerland's Holcim has received more than 60 bids for assets it must sell to win regulatory approval for a merger with Lafarge, the cement company said as it reported third-quarter results that missed expectations. Sales and profit were hurt by a weaker than expected recovery in...

  • *Publicis aims to boost growth after failed Omnicom merger. The French group is hoping rapid growth in both North American and internet advertising, which are far outpacing European and traditional ad formats, will help it catch up with sales gains at rivals such as WPP and Interpublic. Chief Executive Maurice Levy has blamed Publicis' recent poor performance...

  • Labcorp gets into drug research with Covance deal Monday, 3 Nov 2014 | 6:25 AM ET

    Laboratory Corp. of America said it would buy contract research company Covance for about $6.1 billion in cash and stock.

  • UPDATE 2-Holcim profit hit by weak Europe and forex Monday, 3 Nov 2014 | 2:49 AM ET

    ZURICH, Nov 3- Swiss building materials group Holcim posted a drop in quarterly sales and profits on Monday as a recovery in India following May's elections failed to offset foreign exchange headwinds and weakness in Europe and Latin America. The group, which is in the process of merging with France's Lafarge, reported higher sales in markets such as the United...

  • PARIS, Nov 3- Publicis, the world's third-largest advertising holding company, has agreed to buy digital ad specialist Sapient for $3.7 billion in cash as it seeks to accelerate growth after a botched merger earlier this year. For Publicis Chief Executive Maurice Levy, the deal is part of a push to revitalise the group at a time when its quarterly top-line growth...

  • AbbVie: Strong results lessen need for big deal Friday, 31 Oct 2014 | 12:46 PM ET
    Pharmaceuticals health care drugs cost

    AbbVie reported strong earnings on demand for its Humira drug and said it could deliver strong long-term growth without another big merger bid.

  • Oct 31- AbbVie, which this month abandoned its planned $55 billion purchase of Dublin drugmaker Shire, reported impressive quarterly earnings on demand for its Humira arthritis drug and said it could deliver strong long-term growth without rushing into another big merger attempt. "The underlying growth prospects of AbbVie don't require us to do a deal of that...

  • HP tries something new with 3D scanning computer Wednesday, 29 Oct 2014 | 11:00 AM ET

    PALO ALTO, Calif., Oct 29- Hewlett-Packard Co has taken a modest step toward re-imagining the venerable personal computer, merging a 3 D scanner and projector with an all-in-one PC to create a $1,899 ensemble it hopes can rekindle industry interest. The new desktop computer, called Sprout, goes on sale online Wednesday. Sprout sits atop Microsoft's Windows 8 and...